News
-
-
-
-
-
-
PRESS RELEASE
Applied DNA to Announce Second Quarter Fiscal 2025 Financial Results on May 15, Schedules Intra-Quarter Investor Update Call for June 3
Applied DNA Sciences, Inc. to release Q2 fiscal year 2025 financial results on May 15, 2025, with an investor update call on June 3 discussing strategic priorities -
-
-
PRESS RELEASE
Applied DNA's LineaRx Subsidiary Stands Ready to Support the Reshoring of Drug Development and Manufacturing with U.S.-Produced Synthetic DNA
Applied DNA Sciences completes pivot to U.S.-based supply chain for critical input materials with LineaRx, enhancing domestic manufacturing capacities in response to biopharmaceutical industry trends -